Skip to content
Get a Demo

Biotech & pharmaceutical content management solutions

Vodori is specifically designed to help life sciences teams achieve speed and compliance.

Get a Demo View Platform Overview

Trusted by pharmaceutical & biotech companies worldwide

women talking - phram & biotech

A modern approach to regulated content management

If your generic or legacy content management systems make it hard to get content to market, launch campaigns, respond to market conditions, and maintain compliance–it’s time to rethink your solutions. Vodori is a modern, validated platform built exclusively to reduce risk and streamline the review, approval, and distribution processes for pharmaceutical and biotech organizations.

Modern, turnkey regulated content management

Img-Update-01-1

My experience working with Vodori felt like a real partnership. Vodori is responsive and really understands our needs.

Associate Director Sales and Marketing, US pharmaceutical company

Read Reviews

Compare Vodori to other solutions

Vodori comes with turnkey implementation, transparent pricing, and an accelerated time to value. Get a more in-depth comparison to Veeva PromoMats here.

Scroll to the right on the table below to see how Vodori compares to the competition.

FEATURES

Vodori Veeva Vault Box Sharepoint Email
Parallel & sequential review
Version control
Claims management Learn more
Audit support
21 CFR Pt 11 eSignature
Digital content review
Video support

IMPLEMENTATION

Vodori Veeva Vault Box Sharepoint Email
Guaranteed acceptance of configured system
Integrations included (SSO, CRM)
Added costs

ONGOING OPERATIONS

Vodori Veeva Vault Box Sharepoint Email
Validated, quarterly releases
Unlimited configuration changes (no cost)
Unlimited training (no cost)
24x7 user support (email, online chat)
Added costs

Frequently Asked Questions

How can life sciences marketing teams cut promotional review time in half?

Marketing teams shorten review cycles by replacing clunky, legacy software with an AI-powered, validated MLR platform that is easy to use, automatically routes content according to your SOPs, consolidates feedback in one place, and is 21 CFR Part 11 and EU Annex 11 compliant. Vodori customers reduce review cycle times by up to 30% to 60% while improving audit readiness. Based on data found in the 2025 State of Promotional Review Benchmarks Report, pharma companies using Vodori are able to review content in 6.7 days on average.

Which content review platforms handle social media and digital content review for pharma?

Pharma teams need a platform that reviews digital and social content in its native format, not flattened PDFs, so reviewers see what audiences will see and avoid compliance risk. Vodori supports review of promotional, medical, and non-promotional materials across formats, including web pages, HTML, and videos.

Which MLR platforms are 21 CFR Part 11 compliant?

Vodori is 21 CFR Part 11 and EU Annex 11 compliant, with built-in audit trails, claims tracking, and version history. It is also GxP-validated and inspection-tested, and its audit trails are designed to cut audit response time from days to hours.

Which content review tools support FDA Form 2253 submission prep?

Vodori provides health authority submission support that includes preparing materials for FDA Form 2253 submissions. It keeps each asset connected to its approved claims, references, and full review history, so the documentation needed for submission is assembled without manual rework, backed by audit-ready records. With the Vodori platform, you can also control content release until health authority submissions are completed, preventing your organization from unnecessary compliance risk.

What document management systems are built for regulated life sciences workflows?

Generic document management systems store files; systems built for regulated life sciences support the review, approval, and audit controls regulatory bodies expect. Vodori is purpose-built for MLR, with role-based permissions, audit trails, version control, and health authority submission support. It is a cloud-based, GxP-validated platform that connects content, claims, references, and approvals in one system of record and integrates seamlessly with existing DAMs, CRMs, and publishing tools.

How long should an MLR review cycle take in pharma?

Per Vodori's 2025 State of Promotional Review Benchmarks Report, pharma promotional review takes about 6.7 days on average and 3.9 days at the median. Across all industries, review duration averages 7.6 days. The full job, from preparation through final approval, averages 14.8 days across industries (median 6.9). Teams that continuously optimize consistently land at the faster end.

Ready to see what Vodori can do for you?

Let our Sales team walk you through a live, personalized 30 minute demonstration.

Get a Demo